Statins and myositis: the role of anti-HMGCR antibodies
- 22 October 2015
- journal article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 11 (12) , 1277-1279
Abstract
Muscle toxicity is a recognized adverse effect of statin use. Recently, a new myositis syndrome was described in association with antibodies directed against the pharmacologic target of statins, an...Keywords
Funding Information
- Spanish Ministry of Health and Consumer Affairs (PI15-02100)
This publication has 16 references indexed in Scilit:
- Identification of a novel myositis-associated antibody directed against cortactinAutoimmunity Reviews, 2014
- Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing MyopathiesMedicine, 2014
- Analysis of Autoantibodies to 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Using Different TechnologiesJournal of Immunology Research, 2014
- Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodiesArthritis Research & Therapy, 2014
- Statins for millions more?The Lancet, 2014
- The spectrum of statin myopathyCurrent Opinion in Rheumatology, 2013
- Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effectsArthritis Care & Research, 2011
- Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathyArthritis & Rheumatism, 2010
- Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositisRheumatology, 2010
- Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO StudyCardiovascular Drugs and Therapy, 2005